Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Gynecol Obstet Hum Reprod ; 52(3): 102535, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-36657614

RESUMEN

When a patient presents with symptoms suggestive of pelvic organ prolapse (POP), clinical evaluation should include an assessment of symptoms, their impact on daily life and rule out other pelvic pathologies. The prolapse should be described compartment by compartment, indicating the extent of the externalization for each. The diagnosis of POP is clinical. Additional exams may be requested to explore the symptoms associated or not explained by the observed prolapse. Pelvic floor muscle training and pessaries are non-surgical conservative treatment options recommended as first-line therapy for pelvic organ prolapse. They can be offered in combination and be associated with the management of modifiable risk factors for prolapse. If the conservative therapeutic options do not meet the patient's expectations, surgery should be proposed if the symptoms are disabling, related to pelvic organ prolapse, detected on clinical examination and significant (stage 2 or more of the POP-Q classification). Surgical routes for POP repair can be abdominal with mesh placement, or vaginal with autologous tissue. Laparoscopic sacrocolpopexy is recommended for cases of apical and anterior prolapse. Autologous vaginal surgery (including colpocleisis) is a recommended option for elderly and fragile patients. For cases of isolated rectocele, the posterior vaginal route with autologous tissue should be preferentially performed over the transanal route. The decision to place a mesh must be made in consultation with a multidisciplinary team. After the surgery, the patient should be reassessed by the surgeon, even in the absence of symptoms or complications, and in the long term by a primary care or specialist doctor.


Asunto(s)
Enfermedades de los Genitales Femeninos , Prolapso de Órgano Pélvico , Femenino , Humanos , Anciano , Prolapso de Órgano Pélvico/cirugía , Rectocele , Vagina/cirugía , Procedimientos Quirúrgicos Ginecológicos , Diafragma Pélvico/patología
3.
Br J Ophthalmol ; 99(11): 1531-5, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25953846

RESUMEN

BACKGROUND/AIMS: The epidemiology of Graves' orbitopathy (GO) may be changing. The aim of the study was to identify trends in presentation of GO to tertiary centres and initial management over time. METHODS: Prospective observational study of European Group On Graves' Orbitopathy (EUGOGO) centres. All new referrals with a diagnosis of GO over a 4-month period in 2012 were included. Clinical and demographic characteristics, referral timelines and initial decisions about management were recorded. The data were compared with a similar EUGOGO survey performed in 2000. RESULTS: The demographic characteristics of 269 patients studied in 2012 were similar to those collected in the year 2000, including smoking rates (40.0% vs 40.2%). Mild (60.5% vs 41.2%, p<0.01) and inactive GO (63.2% vs 39.9%, p<0.01) were more prevalent in 2012. The times from diagnosis of thyroid disease to being seen in EUGOGO centres (6 vs 16 months) and from first symptoms of GO (9 vs 16 months) or from diagnosis of GO (6 vs 12 months) to first consultation in EUGOGO centres were shorter in 2012 (p<0.01). The initial management plans for GO were no different except surgical treatments for patients with mild inactive disease were more frequently offered in the 2012 cohort than in 2000 (27.3% vs 17%, p<0.05), and selenium supplements were offered only in the 2012 cohort (21.2% vs 0%, p<0.01). CONCLUSIONS: These findings suggest that the clinical manifestations of patients with GO may be changing over time in Europe.


Asunto(s)
Oftalmopatía de Graves/diagnóstico , Oftalmopatía de Graves/epidemiología , Derivación y Consulta/estadística & datos numéricos , Adulto , Europa (Continente)/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Oftalmología/estadística & datos numéricos , Prevalencia , Estudios Prospectivos , Centros de Atención Terciaria/estadística & datos numéricos
4.
Mult Scler ; 19(12): 1618-26, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23462348

RESUMEN

OBJECTIVE: The objective of this article is to evaluate in multiple sclerosis (MS) patients the prevalence of persistent complaints of visual disturbances and the mechanisms and resulting functional disability of persistent visual complaints (PVCs). METHODS: Firstly, the prevalence of PVCs was calculated in 303 MS patients. MS-related data of patients with or without PVCs were compared. Secondly, 70 patients with PVCs performed an extensive neuro-ophthalmologic assessment and a vision-related quality of life questionnaire, the National Eye Institute Visual Functionary Questionnaire (NEI-VFQ-25). RESULTS: PVCs were reported in 105 MS patients (34.6%). Patients with PVCs had more frequently primary progressive MS (30.5% vs 13.6%) and more neuro-ophthalmologic relapses (1.97 vs 1.36) than patients without PVCs. In the mechanisms/disability study, an afferent visual and an ocular-motor pathways dysfunction were respectively diagnosed in 41 and 59 patients, mostly related to bilateral optic neuropathy and bilateral internuclear ophthalmoplegia. The NEI-VFQ 25 score was poor and significantly correlated with the number of impaired neuro-ophthalmologic tests. CONCLUSION: Our study emphasizes the high prevalence of PVC in MS patients. Regarding the nature of neuro-ophthalmologic deficit, our results suggest that persistent optic neuropathy, as part of the progressive evolution of the disease, is not rare. We also demonstrate that isolated ocular motor dysfunctions induce visual disability in daily life.


Asunto(s)
Esclerosis Múltiple/complicaciones , Esclerosis Múltiple/epidemiología , Trastornos de la Visión/epidemiología , Trastornos de la Visión/etiología , Adulto , Anciano , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/psicología , Estudios de Cohortes , Interpretación Estadística de Datos , Evaluación de la Discapacidad , Femenino , Francia/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/fisiopatología , Examen Neurológico , Nistagmo Patológico/etiología , Nistagmo Patológico/fisiopatología , Oftalmoplejía/etiología , Oftalmoplejía/fisiopatología , Prevalencia , Calidad de Vida , Encuestas y Cuestionarios , Trastornos de la Visión/diagnóstico , Trastornos de la Visión/fisiopatología , Pruebas de Visión , Vías Visuales/fisiopatología , Personas con Daño Visual
5.
BMJ Case Rep ; 20102010 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-22789694

RESUMEN

Churg-Strauss syndrome (CSS) is a systemic vasculitis with frequent respiratory tract involvement. It can also affect the nervous system, notably the optic tract. The present work reports the case of a 65-year-old man diagnosed as having CSS in the context of several acute onset neurological symptoms including muscle weakness and signs of temporal arteritis, including bilateral anterior ischaemic optic neuropathy (ON). Electroretinograms (ERGs) and visual evoked potentials (VEPs) were performed. Flash ERGs were normal whereas VEPs were highly abnormal, showing a dramatic voltage reduction, thus confirming the ON. The vision outcome was poor. Ophthalmological presentations of CSS have rarely been reported, but no previous case of sudden blindness documented by combined ERG and VEP investigations were found in the literature. The present case strongly suggests that the occurrence of visual loss in the context of systemic inflammation with hypereosinophilia should lead to considering the diagnosis of CSS.


Asunto(s)
Ceguera/diagnóstico , Síndrome de Churg-Strauss/diagnóstico , Diplopía/diagnóstico , Arteritis de Células Gigantes/diagnóstico , Debilidad Muscular/diagnóstico , Neuropatía Óptica Isquémica/diagnóstico , Anciano , Antiinflamatorios/uso terapéutico , Ceguera/tratamiento farmacológico , Ceguera/fisiopatología , Síndrome de Churg-Strauss/tratamiento farmacológico , Síndrome de Churg-Strauss/fisiopatología , Ciclofosfamida/uso terapéutico , Diplopía/tratamiento farmacológico , Diplopía/fisiopatología , Quimioterapia Combinada , Electromiografía , Electrorretinografía , Potenciales Evocados Visuales/fisiología , Angiografía con Fluoresceína , Arteritis de Células Gigantes/tratamiento farmacológico , Arteritis de Células Gigantes/fisiopatología , Humanos , Inmunosupresores/uso terapéutico , Masculino , Neuropatía Mediana/diagnóstico , Neuropatía Mediana/fisiopatología , Metilprednisolona/uso terapéutico , Debilidad Muscular/tratamiento farmacológico , Debilidad Muscular/fisiopatología , Neuropatía Óptica Isquémica/tratamiento farmacológico , Neuropatía Óptica Isquémica/fisiopatología , Prednisona/uso terapéutico , Tomografía Computarizada por Rayos X
6.
Am J Ophthalmol ; 147(1): 64-70.e2, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18774545

RESUMEN

PURPOSE: To evaluate if optical coherence tomography (OCT), by providing an objective measure of the retinal nerve fiber layer (RNFL) thickness, offers a reliable prediction of visual outcome. DESIGN: Prospective cohort study. METHODS: Thirty-seven eyes of 19 consecutive patients from a single hospital suffering from pituitary adenomas compressing the anterior visual pathways were included, and compared with 46 eyes of 23 controls. Exclusion criteria included any previous treatment of pituitary adenoma and high myopia. Seventeen patients underwent trans-sphenoidal surgery and two patients with macroprolactinomas received dopamine agonists. Automated visual fields (VF) and OCT (fast-RNFL program) were performed before treatment, and two weeks and three months after treatment. RESULTS: Among the eyes with a VF defect before treatment, the odds of complete recovery after three months from the initial VF defect was multiplied by 1.29 for each increase by 1 micron of mean RNFL (odds ratio [OR], 1.29; P = .037). This was independent from age and duration of symptoms, which carried their own prognostic value. Inferior RNFL was a very strong prognostic factor; OR, 6.31 per micron (P = .0000). CONCLUSION: RNFL thinning measured by OCT puts the patient at decreased chance of recovery of an initial VF defect three months after treatment in pituitary adenomas compressing the anterior visual pathways. Further studies will establish how useful this tool is for long-term visual outcome.


Asunto(s)
Adenoma/cirugía , Neoplasias Hipofisarias/cirugía , Tomografía de Coherencia Óptica , Campos Visuales/fisiología , Adenoma/fisiopatología , Adulto , Agonistas de Dopamina/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Síndromes de Compresión Nerviosa/fisiopatología , Fibras Nerviosas/patología , Neoplasias Hipofisarias/fisiopatología , Pronóstico , Prolactinoma/tratamiento farmacológico , Estudios Prospectivos , Células Ganglionares de la Retina/patología , Vías Visuales/fisiopatología
7.
J Adolesc ; 30(6): 977-99, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17400289

RESUMEN

The objective of this qualitative research is to better understand the processes that contribute to resilience among adolescents in foster care. Twelve boys and girls (X=15.9 years), identified as resilient, participated in this study. The mean duration of the teenagers' placement is 7.3 years. The results point to three types of turning points: action, relation and reflection. Four processes, directly or indirectly linked to the turning point, have also been identified: increase in perceived self-efficacy, distancing oneself from the risks, new opportunities, and the multiplication of benefits.


Asunto(s)
Adaptación Psicológica , Cuidados en el Hogar de Adopción/psicología , Psicología del Adolescente , Logro , Adolescente , Carácter , Niño , Maltrato a los Niños/prevención & control , Maltrato a los Niños/psicología , Protección a la Infancia , Femenino , Objetivos , Reducción del Daño , Humanos , Control Interno-Externo , Entrevista Psicológica , Masculino , Motivación , Quebec , Autoeficacia , Conducta Social , Apoyo Social
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...